ANAPTYSBIO INC (ANAB)

US0327241065 - Common Stock

26.58  +0.24 (+0.91%)

After market: 26.345 -0.23 (-0.88%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
17.16M10.29M63.18M75.00M8.00M
Operating Expenses
181.57M125.44M119.99M98.88M115.43M
Research and Development
139.62M88.80M98.50M80.03M99.34M
Selling, General, and Administrative Expenses
41.95M36.64M21.49M18.85M16.09M
Operating Income
-164.41M-115.15M-56.81M-23.88M-107.43M
Interest Income/Expense
18.87M7.55M430.00K3.96M9.94M
Other Income/Expense
-18.09M-21.10M-1.41M-10.00K0.00
Income Before Taxes
-163.62M-128.70M-57.80M-19.93M-97.49M
Income Tax
-4.00K20.00K0.000.00-150.00K
Net Income
-163.62M-128.72M-57.80M-19.93M-97.34M
EBITDA
-163.76M-114.47M-56.19M-23.32M-106.92M
 
Per Share Data
EPS Diluted Total Ops
-6.08-4.57-2.11-0.73-3.60
Non GAAP EPS
-6.08-4.57-2.05-0.76-3.61
 
Statistics
Profit Margin
-953.66%-1250.92%-91.48%-26.57%-1216.75%
Operating Profit Margin
-958.27%-1119.05%-89.92%-31.84%-1342.88%

All data in USD

Charts